tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SLXN Stock Latest News

Silexion Therapeutics is developing a potential “holy grail” play in precision oncology (NASDAQ: SLXN)
TipRanks NewswireSilexion Therapeutics is developing a potential “holy grail” play in precision oncology (NASDAQ: SLXN)
7d ago
SLXN
Silexion Highlights SIL204 RNAi Pancreatic Cancer Program Progress
PremiumCompany Announcements
Silexion Highlights SIL204 RNAi Pancreatic Cancer Program Progress
21d ago
8K
SLXN
Silexion outlines 2026 plans after transformational 2025 progress
PremiumCompany Announcements
Silexion outlines 2026 plans after transformational 2025 progress
2M ago
8K
SLXN
Silexion Therapeutics issues letter to shareholders
PremiumThe Fly
Silexion Therapeutics issues letter to shareholders
2M ago
SLXN
Silexion Therapeutics Submits Phase 2/3 Trial Application
PremiumCompany Announcements
Silexion Therapeutics Submits Phase 2/3 Trial Application
2M ago
8K
SLXN
Silexion submits Phase 2/3 trial application to Israel for SIL204
PremiumThe FlySilexion submits Phase 2/3 trial application to Israel for SIL204
2M ago
SLXN
Silexion Therapeutics initiated with a Buy at Litchfield Hills
Premium
The Fly
Silexion Therapeutics initiated with a Buy at Litchfield Hills
2M ago
SLXN
Buy Recommendation for Silexion Therapeutics: Promising Developments and Market Potential in Pancreatic Cancer Treatment
Premium
Ratings
Buy Recommendation for Silexion Therapeutics: Promising Developments and Market Potential in Pancreatic Cancer Treatment
3M ago
SLXN
Silexion Therapeutics Gains Positive Feedback for SIL204 Trial
PremiumCompany Announcements
Silexion Therapeutics Gains Positive Feedback for SIL204 Trial
3M ago
8K
SLXN
Silexion receives positive feedback from German Health Authority for SIL204
PremiumThe Fly
Silexion receives positive feedback from German Health Authority for SIL204
3M ago
SLXN
Silexion Completes Toxicology Studies for SIL204 Therapy
PremiumCompany Announcements
Silexion Completes Toxicology Studies for SIL204 Therapy
3M ago
8K
SLXN
Silexion Therapeutics completes toxicology studies for SIL204
PremiumThe Fly
Silexion Therapeutics completes toxicology studies for SIL204
3M ago
SLXN
Silexion Therapeutics reports Q3 EPS $2.88 vs $274.25 last year
PremiumThe FlySilexion Therapeutics reports Q3 EPS $2.88 vs $274.25 last year
3M ago
SLXN
Silexion Therapeutics files to sell 1.29M ordinary shares for holders
Premium
The Fly
Silexion Therapeutics files to sell 1.29M ordinary shares for holders
4M ago
SLXN
Buy Rating Affirmed for Silexion Therapeutics: Promising Preclinical Data and Strategic Trial Plans Boost Investment Appeal
Premium
Ratings
Buy Rating Affirmed for Silexion Therapeutics: Promising Preclinical Data and Strategic Trial Plans Boost Investment Appeal
5M ago
SLXN
Silexion Therapeutics Unveils Promising SIL204 Data
PremiumCompany Announcements
Silexion Therapeutics Unveils Promising SIL204 Data
5M ago
8K
SLXN
Silexion Therapeutics announces new data in SIL204
PremiumThe Fly
Silexion Therapeutics announces new data in SIL204
5M ago
SLXN
Silexion Therapeutics files $100M mixed securities shelf
PremiumThe Fly
Silexion Therapeutics files $100M mixed securities shelf
5M ago
SLXN
Silexion Therapeutics Enters Market Offering Agreement
PremiumCompany Announcements
Silexion Therapeutics Enters Market Offering Agreement
5M ago
8K
SLXN
Silexion Therapeutics regains compliance with Nasdaq listing requirements
PremiumThe FlySilexion Therapeutics regains compliance with Nasdaq listing requirements
5M ago
SLXN
Silexion Restores Nasdaq Compliance After Strategic Moves
Premium
Company Announcements
Silexion Restores Nasdaq Compliance After Strategic Moves
5M ago
8K
SLXN
Silexion Therapeutics Converts Debt to Equity for Nasdaq Compliance
Premium
Company Announcements
Silexion Therapeutics Converts Debt to Equity for Nasdaq Compliance
5M ago
8K
SLXN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >